Working women spend $15.4 billion more than men in out-of-pocket health costs, study finds

Working women spend .4 billion more than men in out-of-pocket health costs, study finds


Luis Alvarez | Digitalvision | Getty Images

High health care costs are hitting women in the U.S. workforce much harder than men.

Working women spend $15.4 billion more in out-of-pocket health expenses annually compared to their male counterparts, according to a new analysis of employer-sponsored health plans from Deloitte Consulting.

The study found women spend 18% more than men on co-pays and deductibles, on average. That’s after excluding costs associated with pregnancy and maternity, according to the new report, and despite total health expenditures for women that are just 10% higher than for men.

“This is a problem we’re identifying that business leaders can actually solve within their own organizations. The takeaway being that women get paid less, and that they pay more for health care,” said Dr. Kulleni Gebreyes, U.S. chief health equity officer at Deloitte Consulting.

The result, she said, is a disproportionate financial burden.

Women tend to utilize more medical care than men, in part due to annual gynecological exams and the high costs of breast cancer imaging.

While annual exams are often fully covered, follow-ups that can result from those visits incur co-pays and trigger deductibles. Many of those services are often more expensive than the typical deductible, leading to a higher cost-sharing burden.    

The Deloitte analysts say employers could close the $15.4 billion cost-sharing gender gap through enhanced benefits design, at an estimated cost of $133 per employee per year, or about $11 per month.

“Our ask is that companies look at their data; examine if and where the gaps exist and step back to have more of an equitable design process to come up with what are the health benefits that would meet the needs of their workforce,” said Gebreyes.



Source

JPMorgan’s top biotech and pharma picks for the second half
Health

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]

Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More